TP53 and carcinoma: The conventional adenoma-carcinoma-metastasis model occurs in ~70% of CRCs, which is associated with metabolic alterations caused by “APC-KRAS-TP53” specific genetic alteration (Vogelstein model) [37], and metabolic reprogramming is essential for the initiation and progression of CRC.